mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.6 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.16 |
0.6 |